1-2 of 2
Alessio Papi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion

Fulvia Farabegoli, Marzia Govoni, Enzo Spisni, Alessio Papi
Journal: Bioscience Reports
Biosci Rep (2017) 37 (3): BSR20170168.
https://doi.org/10.1042/BSR20170168
Published: 17 May 2017
View articletitled, EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion
Open the PDF for EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion in another window
Includes: Supplementary data
Articles

(–)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells

Fulvia Farabegoli, Alessio Papi, Marina Orlandi
Journal: Bioscience Reports
Biosci Rep (2011) 31 (2): 99–108.
https://doi.org/10.1042/BSR20090143
Published: 29 October 2010
View articletitled, (–)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells
Open the PDF for (–)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells in another window
Includes: Supplementary data